The Effect of Pulse Sequence Parameters and Contrast Agent Dose on Percentage Signal Recovery in DSC-MRI: Implications for Clinical Applications

REFERENCES

1. 1.↵
   1. Liu X,
   2. Kolar B,
   3. Tian W,
   4. et al

   . MR perfusion-weighted imaging may help in differentiating between nonenhancing gliomas and nonneoplastic lesions in the cervicomedullary junction. J Magn Reson Imaging 2011;34:196–202

   CrossRefPubMed
2. 2.↵
   1. Barajas RF,
   2. Chang JS,
   3. Sneed PK,
   4. et al

   . Distinguishing recurrent intra-axial metastatic tumor from radiation necrosis following gamma knife radiosurgery using dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. AJNR Am J Neuroradiol 2009;30:367–72

   Abstract/FREE Full Text
3. 3.↵
   1. Huang J,
   2. Wang AM,
   3. Shetty A,
   4. et al

   . Differentiation between intra-axial metastatic tumor progression and radiation injury following fractionated radiation therapy or stereotactic radiosurgery using MR spectroscopy, perfusion MR imaging or volume progression modeling. Magn Reson Imaging 2011;29:993–1001

   CrossRefPubMedWeb of Science
4. 4.↵
   1. Barajas RF Jr.,
   2. Chang JS,
   3. Segal MR,
   4. et al

   . Differentiation of recurrent glioblastoma multiforme from radiation necrosis after external beam radiation therapy with dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. Radiology 2009;253:486–96

   CrossRefPubMedWeb of Science
5. 5.↵
   1. Cha S,
   2. Lupo JM,
   3. Chen MH,
   4. et al

   . Differentiation of glioblastoma multiforme and single brain metastasis by peak height and percentage of signal intensity recovery derived from dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. AJNR Am J Neuroradiol 2007;28:1078–84

   Abstract/FREE Full Text
6. 6.↵
   1. Liao W,
   2. Liu Y,
   3. Wang X,
   4. et al

   . Differentiation of primary central nervous system lymphoma and high-grade glioma with dynamic susceptibility contrast-enhanced perfusion magnetic resonance imaging. Acta Radiol 2009;50:217–25

   Abstract/FREE Full Text
7. 7.↵
   1. Mangla R,
   2. Kolar B,
   3. Zhu T,
   4. et al

   . Percentage signal recovery derived from MR dynamic susceptibility contrast imaging is useful to differentiate common enhancing malignant lesions of the brain. AJNR Am J Neuroradiol 2011;32:1004–10

   Abstract/FREE Full Text
8. 8.↵
   1. Mouthuy N,
   2. Cosnard G,
   3. Abarca-Quinones J,
   4. et al

   . Multiparametric magnetic resonance imaging to differentiate high-grade gliomas and brain metastases. J Neuroradiol 2012;39:301–07

   CrossRefPubMed
9. 9.↵
   1. Boxerman JL,
   2. Schmainda KM,
   3. Weisskoff RM

   . Relative cerebral blood volume maps corrected for contrast agent extravasation significantly correlate with glioma tumor grade, whereas uncorrected maps do not. AJNR Am J Neuroradiol 2006;27:859–67

   Abstract/FREE Full Text
10. 10.↵
    1. Boxerman JL,
    2. Prah DE,
    3. Paulson ES,
    4. et al

    . The role of preload and leakage correction in gadolinium-based cerebral blood volume estimation determined by comparison with MION as a criterion standard. AJNR Am J Neuroradiol 2012;33:1081–87

    Abstract/FREE Full Text
11. 11.↵
    1. Levin JM,
    2. Kaufman MJ,
    3. Ross MH,
    4. et al

    . Sequential dynamic susceptibility contrast MR experiments in human brain: residual contrast agent effect, steady state, and hemodynamic perturbation. Magn Reson Med 1995;34:655–63

    PubMed
12. 12.↵
    1. Paulson ES,
    2. Schmainda KM

    . Comparison of dynamic susceptibility-weighted contrast-enhanced MR methods: recommendations for measuring relative cerebral blood volume in brain tumors. Radiology 2008;249:601–13

    CrossRefPubMedWeb of Science
13. 13.↵
    1. Cha S,
    2. Lu S,
    3. Johnson G,
    4. et al

    . Dynamic susceptibility contrast MR imaging: correlation of signal intensity changes with cerebral blood volume measurements. J Magn Reson Imaging 2000;11:114–19

    CrossRefPubMed
14. 14.↵
    1. Law M,
    2. Yang S,
    3. Babb JS,
    4. et al

    . Comparison of cerebral blood volume and vascular permeability from dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade. AJNR Am J Neuroradiol 2004;25:746–55

    Abstract/FREE Full Text
15. 15.↵
    1. Lee MC,
    2. Cha S,
    3. Chang SM,
    4. et al

    . Dynamic susceptibility contrast perfusion imaging of radiation effects in normal-appearing brain tissue: changes in the first-pass and recirculation phases. J Magn Reson Imaging 2005;21:683–93

    CrossRefPubMedWeb of Science
16. 16.↵
    1. Vonken EP,
    2. van Osch MJ,
    3. Bakker CJ,
    4. et al

    . Simultaneous quantitative cerebral perfusion and Gd-DTPA extravasation measurement with dual-echo dynamic susceptibility contrast MRI. Magn Reson Med 2000;43:820–27

    CrossRefPubMedWeb of Science
17. 17.↵
    1. Uematsu H,
    2. Maeda M,
    3. Sadato N,
    4. et al

    . Blood volume of gliomas determined by double-echo dynamic perfusion-weighted MR imaging: a preliminary study. AJNR Am J Neuroradiol 2001;22:1915–19

    Abstract/FREE Full Text
18. 18.↵
    1. Donahue KM,
    2. Krouwer HG,
    3. Rand SD,
    4. et al

    . Utility of simultaneously acquired gradient-echo and spin-echo cerebral blood volume and morphology maps in brain tumor patients. Magn Reson Med 2000;43:845–53

    CrossRefPubMedWeb of Science
19. 19.↵
    1. Schmainda KM,
    2. Rand SD,
    3. Joseph AM,
    4. et al

    . Characterization of a first-pass gradient-echo spin-echo method to predict brain tumor grade and angiogenesis. AJNR Am J Neuroradiol 2004;25:1524–32

    Abstract/FREE Full Text
20. 20.↵
    1. Paulson ES,
    2. Prah DE,
    3. Schmainda KM

    . Correction of confounding leakage and residual susceptibility effects in dynamic susceptibility contrast MR imaging using dual-echo SPIRAL. In: Proceedings of the 45th Annual Meeting of the American Society of Neuroradiology and Neuroradiology Education and Research Foundation Symposium, Chicago, Illinois; June 7–14, 2007
21. 21.↵
    1. Quarles CC,
    2. Gochberg DF,
    3. Gore JC,
    4. et al

    . A theoretical framework to model DSC-MRI data acquired in the presence of contrast agent extravasation. Phys Med Biol 2009;54:5749–66

    CrossRefPubMed
22. 22.↵
    1. Boxerman JL,
    2. Rosen BR,
    3. Weisskoff RM

    . Signal-to-noise analysis of cerebral blood volume maps from dynamic NMR imaging studies. J Magn Reson Imaging 1997;7:528–37

    PubMed